US 11052103
Patatin-like phospholipase domain containing 3 (PNPLA3) iRNA compositions and methods of use thereof
granted A61KA61K31/7125A61P
Quick answer
US patent 11052103 (Patatin-like phospholipase domain containing 3 (PNPLA3) iRNA compositions and methods of use thereof) held by Alnylam Pharmaceuticals, Inc. expires Mon Jul 01 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Alnylam Pharmaceuticals, Inc.
- Grant date
- Tue Jul 06 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 01 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 39
- CPC classes
- A61K, A61K31/7125, A61P, A61P1/16, A61P3/06